A newly developed blood test for Alzheimer's disease not only aids in the diagnosis of the neurodegenerative condition but also indicates how far it has progressed, according to a new study.

A new "highly accurate" blood test for Alzheimer's disease also measures how far it has progressed. It could help enable ...

Eli Lilly's Alzheimer's treatment is approved for use in the U.S. but the European Medicines Agency recommended against the ...

Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...

A newly developed blood test for Alzheimer's disease not only aids in the diagnosis of the neurodegenerative condition but ...

Nearly every modern medical treatment can be traced to research funded by the National Institutes of Health: from ...

Luye Pharma Group today announced that marketing approval for its innovative formulation Rivastigmine Twice Weekly Transdermal Patch has been granted by the Japanese Ministry of Health, Labour and ...

In a recent post that has been viewed more than three million times, Dr Amy Shah implored her followers not to use hugely ...

Algorae Pharmaceuticals (ASX: 1AI) has received a tax rebate of $451,359 from the Australian Taxation Office (ATO) for ...

The Government intends to implement a long-term health programme offering care for seniors living with dementia. Speaking in the House of Assembly on Friday, Tinée Furbert, the youth, social ...

The EMA has recommended refusing marketing authorization for donanemab, a monoclonal antibody against amyloid beta, in the ...

Accumulation of a protein called TDP-43 is a key feature of ALS and frontotemporal dementia. In a study published in Neuron, ...